Deepak Nath, PhD, will begin his role as CEO of Smith+Nephew April 1 after spending the last four years with Siemens Healthineers.
Eight things to know:
1. Dr. Nath succeeds Roland Diggelmann, who served as CEO since 2019 and navigated the company through the COVID-19 pandemic.
2. At Siemens, Dr. Nath served as president of the laboratory diagnostics segment, where he oversaw 15,000 employees and was responsible for $6 billion in sales.
3. One key highlight from his Siemens tenure was his spearheading of a program to drive growth and margin expansion through improved execution and a strong results-focused culture, Smith+Nephew said when Dr. Nath's appointment was announced.
4. Prior to Siemens, he spent more than 10 years at Abbott in several executive leadership positions, including president of the company's vascular division and senior vice president of its laboratories business.
5. He played a key role in Abbott's $28 billion acquisition of St. Jude Medical in 2017.
6. "[Dr. Nath] is a highly experienced leader with a track record of significant improvement in operations and execution at major global healthcare businesses," Smith+Nephew Chair Roberto Quarta said. "He is joining us at an inflection point for the business and will bring his drive, experience and expertise to lead the team in delivering our strategy for growth at pace."
7. He has a master's degree in mechanical engineering and a PhD in theoretical mechanics from the University of California Berkeley.
8. Dr. Nath's base salary at Smith+Nephew will be $1.5 million.